{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:56:47Z","timestamp":1787065007814,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Early recurrence of atrial tachyarrhythmia (ER) is predictive of late recurrence of atrial tachyarrhythmia (LR) after first-time atrial fibrillation (AF) ablation, but the association in patients undergoing repeat AF ablation is unknown. We aim to determine the incidence and prognostic significance of ER after repeat ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 259 consecutive patients (mean age 64 years, 75.3% male) undergoing repeat AF ablation with complete follow-up data were included at a single institution from 2010 to 2015. ER and LR were defined as atrial tachyarrhythmia (AF, atrial flutter or atrial tachycardia) &gt; 30 s within the 3-month blanking period (BP) and after the 3-month BP, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ER occurred in 79\/259 (30.5%), and LR occurred in 138\/259 (53%) at a median follow-up of 1221 (IQR: 523\u20131712) days. Four-year freedom from LR was 22% and 56% in patients with and without ER, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). After multivariate adjustment, ER was strongly associated with LR, cardioversion post BP, and repeat ablation, but not associated with hospitalization. Compared to those with no ER, there was a higher risk of LR when ER occurred within the first month of the BP [month 1: hazard ratio (HR) 2.32, confidence interval (CI) 1.57\u20133.74,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001; month 2: HR 2.01, CI 1.13\u20133.83,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.02; month 3: HR 1.46, CI 0.5\u20133.36,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.37], however\u00a0the prediction of LR based on timing within the BP was poor (area under curve 0.64).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Following repeat AF ablation, ER is strongly associated with LR, cardioversion post BP, and repeat ablation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10840-021-00987-z","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T03:03:03Z","timestamp":1617764583000},"page":"323-331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between early recurrences of atrial tachyarrhythmias and long-term outcomes in patients after repeat atrial fibrillation ablation"],"prefix":"10.1007","volume":"64","author":[{"given":"Douglas","family":"Darden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Aldaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya L.","family":"Malladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praneet S.","family":"Mylavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick T.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt S.","family":"Hoffmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Raissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Krummen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory K.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-573X","authenticated-orcid":false,"given":"Jonathan C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"issue":"10","key":"987_CR1","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Heart Rhythm. 2017;14(10):e445\u2013e94. https:\/\/doi.org\/10.1016\/j.hrthm.2017.07.009.","journal-title":"Heart Rhythm."},{"issue":"1","key":"987_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1540-8159.2011.03256.x","volume":"35","author":"JG Andrade","year":"2012","unstructured":"Andrade JG, Khairy P, Verma A, Guerra PG, Dubuc M, Rivard L, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012;35(1):106\u201316. https:\/\/doi.org\/10.1111\/j.1540-8159.2011.03256.x.","journal-title":"Pacing Clin Electrophysiol."},{"issue":"1","key":"987_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/CIRCEP.113.000876","volume":"7","author":"HS Lim","year":"2014","unstructured":"Lim HS, Schultz C, Dang J, Alasady M, Lau DH, Brooks AG, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(1):83\u20139. https:\/\/doi.org\/10.1161\/CIRCEP.113.000876.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"1","key":"987_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/CIRCEP.113.000586","volume":"7","author":"JG Andrade","year":"2014","unstructured":"Andrade JG, Khairy P, Macle L, Packer DL, Lehmann JW, Holcomb RG, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol. 2014;7(1):69\u201375. https:\/\/doi.org\/10.1161\/CIRCEP.113.000586.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"5","key":"987_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.hrthm.2008.01.031","volume":"5","author":"S Themistoclakis","year":"2008","unstructured":"Themistoclakis S, Schweikert RA, Saliba WI, Bonso A, Rossillo A, Bader G, et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm. 2008;5(5):679\u201385. https:\/\/doi.org\/10.1016\/j.hrthm.2008.01.031.","journal-title":"Heart Rhythm."},{"issue":"12","key":"987_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1540-8167.2010.01831.x","volume":"21","author":"JI Choi","year":"2010","unstructured":"Choi JI, Pak HN, Park JS, Kwak JJ, Nagamoto Y, Lim HE, et al. Clinical significance of early recurrences of atrial tachycardia after atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2010;21(12):1331\u20137. https:\/\/doi.org\/10.1111\/j.1540-8167.2010.01831.x.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"4","key":"987_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCEP.115.003095","volume":"8","author":"M Das","year":"2015","unstructured":"Das M, Wynn GJ, Morgan M, Lodge B, Waktare JE, Todd DM, et al. Recurrence of atrial tachyarrhythmia during the second month of the blanking period is associated with more extensive pulmonary vein reconnection at repeat electrophysiology study. Circ Arrhythm Electrophysiol. 2015;8(4):846\u201352. https:\/\/doi.org\/10.1161\/CIRCEP.115.003095.","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"987_CR8","doi-asserted-by":"publisher","unstructured":"Willems S, Khairy P, Andrade JG, Hoffmann BA, Levesque S, Verma A, et al. Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) Trial. Circ Arrhythm Electrophysiol. 2016;9(8). https:\/\/doi.org\/10.1161\/CIRCEP.115.003909.","DOI":"10.1161\/CIRCEP.115.003909"},{"issue":"12","key":"987_CR9","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.hrthm.2015.07.015","volume":"12","author":"JJ Liang","year":"2015","unstructured":"Liang JJ, Elafros MA, Chik WW, Santangeli P, Zado ES, Frankel DS, et al. Early recurrence of atrial arrhythmias following pulmonary vein antral isolation: timing and frequency of early recurrences predicts long-term ablation success. Heart Rhythm. 2015;12(12):2461\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2015.07.015.","journal-title":"Heart Rhythm."},{"issue":"19","key":"987_CR10","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2012.04.060","volume":"60","author":"RR Tilz","year":"2012","unstructured":"Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol. 2012;60(19):1921\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.060.","journal-title":"J Am Coll Cardiol."},{"issue":"12","key":"987_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/j.1540-8167.2012.02399.x","volume":"23","author":"JG Andrade","year":"2012","unstructured":"Andrade JG, Macle L, Khairy P, Khaykin Y, Mantovan R, De Martino G, et al. Incidence and significance of early recurrences associated with different ablation strategies for AF: a STAR-AF substudy. J Cardiovasc Electrophysiol. 2012;23(12):1295\u2013301. https:\/\/doi.org\/10.1111\/j.1540-8167.2012.02399.x.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"10","key":"987_CR12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.hrthm.2009.06.014","volume":"6","author":"M Bhargava","year":"2009","unstructured":"Bhargava M, Di Biase L, Mohanty P, Prasad S, Martin DO, Williams-Andrews M, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm. 2009;6(10):1403\u201312. https:\/\/doi.org\/10.1016\/j.hrthm.2009.06.014.","journal-title":"Heart Rhythm."},{"issue":"23","key":"987_CR13","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1161\/CIRCULATIONAHA.110.946806","volume":"122","author":"F Ouyang","year":"2010","unstructured":"Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122(23):2368\u201377. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.946806.","journal-title":"Circulation."},{"issue":"2","key":"987_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jacc.2010.05.061","volume":"57","author":"R Weerasooriya","year":"2011","unstructured":"Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57(2):160\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.061.","journal-title":"J Am Coll Cardiol."},{"issue":"9","key":"987_CR15","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.hrthm.2011.04.012","volume":"8","author":"T Rostock","year":"2011","unstructured":"Rostock T, Salukhe TV, Steven D, Drewitz I, Hoffmann BA, Bock K, et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation. Heart Rhythm. 2011;8(9):1391\u20137. https:\/\/doi.org\/10.1016\/j.hrthm.2011.04.012.","journal-title":"Heart Rhythm."},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10840-020-00741-x","volume":"60","author":"G Hodges","year":"2020","unstructured":"Hodges G, Bang CN, Torp-Pedersen C, Hansen ML, Schjerning AM, Hansen J, et al. Significance of early recurrence of atrial fibrillation after catheter ablation: a nationwide Danish cohort study. J Interv Card Electrophysiol. 2020;60:271\u20138. https:\/\/doi.org\/10.1007\/s10840-020-00741-x.","journal-title":"J Interv Card Electrophysiol."},{"issue":"5","key":"987_CR17","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.4022\/jafib.1726","volume":"10","author":"JJ Liang","year":"2018","unstructured":"Liang JJ, Dixit S. Early recurrences during the blanking period after atrial fibrillation ablation. J Atr Fibrillation. 2018;10(5):1726. https:\/\/doi.org\/10.4022\/jafib.1726.","journal-title":"J Atr Fibrillation."},{"issue":"1","key":"987_CR18","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.1038\/s41598-018-28072-y","volume":"8","author":"N Mujovi\u0107","year":"2018","unstructured":"Mujovi\u0107 N, Marinkovi\u0107 M, Markovi\u0107 N, Vu\u010di\u0107evi\u0107 V, Lip GYH, Bunch TJ, et al. The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. Sci Rep. 2018;8(1):9875. https:\/\/doi.org\/10.1038\/s41598-018-28072-y.","journal-title":"Sci Rep."},{"issue":"6","key":"987_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1540-8167.2008.01188.x","volume":"19","author":"N Lellouche","year":"2008","unstructured":"Lellouche N, Ja\u00efs P, Nault I, Wright M, Bevilacqua M, Knecht S, et al. Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J Cardiovasc Electrophysiol. 2008;19(6):599\u2013605. https:\/\/doi.org\/10.1111\/j.1540-8167.2008.01188.x.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"10","key":"987_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.amjcard.2019.08.009","volume":"124","author":"OM Aldaas","year":"2019","unstructured":"Aldaas OM, Lupercio F, Han FT, Hoffmayer KS, Krummen D, Ho G, et al. Meta-analysis of effect of modest (\u226510%) weight loss in management of overweight and obese patients with atrial fibrillation. Am J Cardiol. 2019;124(10):1568\u201374. https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.009.","journal-title":"Am J Cardiol."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-00987-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-021-00987-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-00987-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:12:07Z","timestamp":1661213527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-021-00987-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1007\/s10840-021-00987-z","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"13 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of University of California, San Diego.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Dr. Hsu reports receiving honoraria from Medtronic, Abbott, Boston Scientific, Biotronik, Janssen Pharmaceuticals, Bristol-Myers Squibb, Altathera Pharmaceuticals, Zoll Medical, and Biosense-Webster; equity in Acutus Medical and Vektor Medical; and research grants from Biotronik and Biosense-Webster. Dr. Ho receives grant support from the American Heart Association (AHA 19CDA34760021), National Institutes of Health (NIH 1KL2TR001444), and reports equity in Vektor Medical Inc. unrelated to this work. Dr. Krummen reports receiving a research grant from the University Galvanizing Engineering in Medicine Foundation, equity in Vektor Medical unrelated to the present work, and fellowship support from Abbott, Biosense-Webster, Biotronik, Boston Scientific, and Medtronic. Dr. Feld reports equity in Acutus Medical, Inc., Vektor Medical, Inc., and Perminova, Inc.; has received honoraria from Altathera Pharmaceuticals, Inc., Vektor Medical, Inc., and Acutus Medical, Inc.; and, as EP Fellowship Training Program Director, indirectly receives fellowship stipend support from Abbott, Inc., Boston Scientific, Inc., Biotronik, Inc., and Biosense Webster, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}